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Abstract
Background: Various protein expression systems, such as Escherichia coli (E. coli), Saccharomyces cerevisiae
(S. cerevisiae), Pichia pastoris (P. pastoris), insect cells and mammalian cell lines, have been developed for the
synthesis of G protein-coupled receptors (GPCRs) for structural studies. Recently, the crystal structures of four
recombinant human GPCRs, namely b2 adrenergic receptor, adenosine A2a receptor, CXCR4 and dopamine D3
receptor, were successfully determined using an insect cell expression system. GPCRs expressed in insect cells are
believed to undergo mammalian-like posttranscriptional modifications and have similar functional properties than
in mammals. Crystal structures of GPCRs have not yet been solved using yeast expression systems. In the present
study, P. pastoris and insect cell expression systems for the human muscarinic acetylcholine receptor M2 subtype
(CHRM2) were developed and the quantity and quality of CHRM2 synthesized by both expression systems were
compared for the application in structural studies.
Results: The ideal conditions for the expression of CHRM2 in P. pastoris were 60 hr at 20°C in a buffer of pH 7.0.
The specific activity of the expressed CHRM2 was 28.9 pmol/mg of membrane protein as determined by binding
assays using [
3H]-quinuclidinyl benzilate (QNB). Although the specific activity of the protein produced by P. pastoris
was lower than that of Sf9 insect cells, CHRM2 yield in P. pastoris was 2-fold higher than in Sf9 insect cells because
P. pastoris was cultured at high cell density. The dissociation constant (Kd) for QNB in P. pastoris was 101.14 ± 15.07
pM, which was similar to that in Sf9 insect cells (86.23 ± 8.57 pM). There were no differences in the binding affinity
of CHRM2 for QNB between P. pastoris and Sf9 insect cells.
Conclusion: Compared to insect cells, P. pastoris is easier to handle, can be grown at lower cost, and can be
expressed quicker at a large scale. Yeast, P. pastoris, and insect cells are all effective expression systems for GPCRs.
The results of the present study strongly suggested that protein expression in P. pastoris can be applied to the
structural and biochemical studies of GPCRs.
Background
G protein-coupled receptors (GPCRs) belong to the lar-
gest superfamily of cell surface receptors. The GPCRs
are integral transmembrane proteins and mediate var-
ious cellular responses to specific functional ligands
including amine, eicosanoid, hormone and peptide, as
well as taste and light stimuli. Approximately 50% of all
currently available drugs act through GPCRs [1,2].
GPCRs are among the most important therapeutic
targets for various disorders. Structure guided drug
development is therefore important for the design of
novel drugs devoid of side effects.
The crystal structure of membrane proteins such as
GPCRs is difficult to solve due to several technical bot-
tlenecks. One of the main obstacles for the resolution of
crystal structures is the preparation of sufficiently large
amounts of functional GPCR protein [3]. Milligram
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any medium, provided the original work is properly cited.quantities of purified protein are required for crystalliza-
tion and structural determination. Bovine rhodopsin [4],
bovine opsin [5] and squid rhodopsin [6,7], whose crys-
tal structures have been solved, are expressed in large
amounts endogenously, and therefore can be obtained
from natural sources, whereas other GPCRs cannot be
purified in large amounts from natural tissues because
of their low endogenous expression levels. In addition to
insect cells [8-16], various expression systems can be
applied to obtain a high yield of GPCRs, such as Escher-
ichia coli [17-21], Saccharomyces cerevisiae [22,23],
Pichia pastoris [24-30], mammalian cell lines [31-33],
and a cell-free translation system [34-39]. We previously
identified 25 GPCRs expressed by P. pastoris [29], which
led us to suggest that P. pastoris i sas u i t a b l eh o s tf o r
GPCR crystal structural studies. However, the crystal
structures of recombinant human b2-adrenergic receptor
(ADRB2) [40,41], human adenosine A2A receptor
(ADORA2A) [42], human CXCR4 chemokine receptor
[43], human dopamine D3 receptor [44] and turkey b1-
adrenergic receptor (ADRB1) [13] have been determined
successfully using only insect cells, in the present study,
the quality and quantity of GPCRs expressed in P. pas-
toris were compared directly with those from Sf9 insect
cells. Together with our previous study, the results show
clearly that the P. pastoris expression system is an effi-
cient system for GPCR production.
T h em u s c a r i n i ca c e t y l c h o l i n er e c e p t o r( C H R M )
belongs to the GPCR superfamily and plays important
roles in signal transduction in the central and periph-
eral nervous systems [45,46]. The muscarinic actions
of acetylcholine in central and peripheral physiological
and pathophysiological processes are mediated by five
molecularly distinct CHRMs labeled 1-5 [47-51]. One
of the structural properties of all CHRM subtypes is a
long third intracellular loop (i3) composed of about
160-240 amino acid residues. Prior studies have
attempted to express human CHRM2 with a deletion
in the central part of the third intracellular loop from
Ser234 to Arg381 using various expression systems,
including E. coli [17,18], P. pastoris [29], and insect
cells [52].
The present study focuses on the potential of P. pas-
toris to express GPCR proteins that are adequate for
structural analysis. The X-ray crystal structures of sev-
eral membrane proteins, including the mammalian
potassium channel [53] and the molluscan acetylcho-
line-binding protein [54], were successfully solved using
the P. pastoris expression system. Insect cell-based
expression systems have certain disadvantages for pro-
tein expression compared to P. pastoris,s u c ha sm o r e
involved and costlier culture requirements, as well as
the difficulty in developing large-scale fermentation sys-
tems. Furthermore, the preparation of sufficient
amounts of baculovirus for large-scale expression is
time consuming. P. pastoris expression systems, on the
other hand, are easily controlled for the optimization of
growth conditions for the induction of the receptor of
interest, including culture scale, temperature, time and
pH value. In the present study, the quality and quantity
of CHRM2 protein produced from P. pastoris and insect
cells were compared for their potential use in structural
studies of GPCRs.
Results
Comparison between culture conditions in P. pastoris and
Sf9 insect cells during receptor overexpression
In the crystal structure determination of turkey ADRB1,
human ADRB2, and human ADORA2A, all three
GPCRs were produced as recombinant proteins in Sf9
or High-5 insect cells. However, the yeast P. pastoris
can grow rapidly, can reach high cell densities, and it
contains the necessary elements to perform posttransla-
tional modifications that might be essential for protein
function. The use of a tightly regulated strong promoter,
alcohol oxidase 1 (AOX1), which is inducible by metha-
nol as the sole carbon source, enables the production of
a large amount of recombinant GPCRs in P. pastoris.
Figure 1A shows the temporal differences between
GPCR expression using P. pastoris or Sf9 insect cells
from expression vector construction to large-scale
expression. The total time to large-scale expression was
about 24-28 days in P. pastoris compared to about 40-
45 days in Sf9 insect cells, with a temporal difference of
17-21 days between the systems. Thus, the P. pastoris
expression system required less time to generate suitable
clones for various GPCRs for crystal structural study.
Figure 1B shows the construction of recombinant
CHRM2 as a model protein for structural analysis using
2 expression systems.
Culture conditions such as cell density, nutrient meta-
bolism and pH, which contribute to optimal recombi-
nant protein production, were compared between P.
pastoris and insect cells. P. pastoris transformants were
inoculated and grown in BMGY medium, in which gly-
cerol was the sole carbon source, overnight or until an
OD600 of 2-6 was reached. The cells were then har-
vested by centrifugation. To induce expression of the
protein of interest by methanol, the cell pellet was
resuspended to an OD600 of 1.0, corresponding to 5 ×
10
7 cells/ml in BMMY medium (0.5% methanol). The
cell density increased up to 2.4 ± 0.3 × 10
9 cells/ml in
the baffled shake flask until 3 days after methanol
induction of the recombinant protein (Figure 2A).
Methanol was added to a final concentration of 1%
every 24 hr during the induction phase, maintaining the
total concentration between 0.5% and 1.5% to minimize
toxicity (Figure 2B). The pH in the induction medium
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Figure 1 Schema of GPCR expression in P. pastoris and Sf9 insect cells and human CHRM2 mutant. The CHRM2-expressing plasmid
vector was constructed (Vac.). In the P. pastoris expression system, the plasmid was transformed into the P. pastoris strain SMD1163. The
transformants were inoculated onto MD plates (MD) and selected by YPD agar plates containing G418 (0.1 or 0.25 mg/mL) (Gen). In the Sf9
insect cell expression system, baculovirus was obtained by homologous recombination in E. coli using the Bac-to-Bac baculovirus expression
system (Invitrogen) (Bac.). Baculoviruses were amplified stepwise (P1 and P2). Small- and large-scale cultures are shown in yellow and orange,
respectively. Evaluation by a ligand-binding assay is represented in green (A). Four N-linked glycosylation sites in the N-terminus were eliminated
by converting asparagine residues (Asn2, 3, 6 and 9) to aspartic acid (Asp). Amino acid residues 234- 381 of the third intracellular loop of the
human CHRM2 were deleted (B).
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Figure 2 Comparison of culture conditions in P. pastoris and Sf9 insect cells.I nP. pastoris, cell density (A), methanol concentration (B), and
pH (C) were measured until 5 days after methanol induction. Cell density was estimated from OD600. Methanol concentration was monitored
before and after methanol addition using a methanol sensor system (RAVEN Biotech Inc.). In Sf9 insect cells, cell density (D), glucose
concentration (E), and pH (F) were measured during the period from preculture (4 days) to baculovirus infection (2 days). Cells were stained with
0.25% trypan blue in PBS (-) and living cells were counted with a hemocytometer.
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Page 4 of 13gradually decreased, requiring 5 days for a reduction
from 7.0 to 6.5 ± 0.2 (Figure 2C).
For the generation of baculovirus-infected Sf9 insect
cells, baculovirus was added at a multiplicity of infec-
tions (MOI) of 2 when insect cells reached 5.0 ± 0.3 ×
10
6 cells/ml, showing a viability greater than 95% in the
cellbag using the Wave Bioreactor system. A period of 4
days was necessary to achieve the desired cell density
from the seeding at 1.0 × 10
6 cells/ml. In contrast to the
viability of P. pastoris during the production of recombi-
nant CHRM2, Sf9 cell density decreased progressively
after the baculovirus infection (Figure 2D). Glucose con-
tent decreased in a time-dependent manner (Figure 2E)
and the pH in the culture medium remained constant at
approximately 6.4 during the 4 preculture days, but
rapidly decreased from 6.1 to 5.5 ± 0.1 in the 2 days
after baculovirus infection (Figure 2F). The diameter of
the Sf9 insect cells, which can be used as an indicator of
viral infection,i n c r e a s e db y> 1μm after 2 days of viral
infection compared with uninfected Sf9 insect cells (see
Fig. S1 in additional file 1).
Optimization of CHRM2 expression parameters in P.
pastoris
The optimization of expression conditions, including
induction time, temperature and pH, can be controlled
in small-scale P. pastoris cultures during methanol
induction for the production of the highest levels of the
protein of interest. Whereas the scaling-up of the cul-
ture system in Sf9 insect cells decreased the production
of CHRM2 (data not shown), the expression levels of
CHRM2 in P. pastoris increased in correlation with the
scale-up of the cell culture [29]. Specific binding of [
3H]
QNB continued to increase up to 60 hr at 20°C in pH
6.0, 7.0 and 8.0 (Figure 3A, B and 3C). The expression
levels of CHRM2 at 30°C were lower than those at 20°C
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Figure 3 Optimization of P. pastoris culture conditions. P. pastoris was cultured in various conditions and the expression levels of CHRM2
were estimated by specific ligand binding assay. To find the optimal growth conditions, the pH of the medium at 6.0 (A), 7.0 (B) and 8.0 (C), the
induction temperature (20 or 30°C), and expression times (20, 40 and 60 hr) were evaluated in all possible combinations.
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Page 5 of 13under most conditions (Figure 3A, B and 3C). The pH
of the culture medium did not affect the expression
levels. The highest specific activity (28.9 pmol/mg of
membrane protein) was obtained under optimized con-
ditions (60 hr, pH 7.0, 20°C).
Quantity and quality of CHRM2 expressed in P. Pastoris
and Sf9 insect cells
The preparation of large quantities of CHRM2 posses-
sing the appropriate ligand binding activity or affinity is
necessary for structural studies. A comparison of the
quality and quantity of CHRM2 expressed through large
scale cultures of P. pastoris and Sf9 insect cells was per-
formed by competition binding assays with [
3H]QNB
(Figure 4). A maximum specific activity was reached at
17.2 ± 1.0 pmol/mg of membrane in P. pastoris on day
3 after methanol induction and the high expression level
was maintained until day 4 (Figure 4A). In contrast, the
maximum specific activity of CHRM2 in Sf9 insect cells
was obtained at 23.2 ± 8.0 pmol/mg of membrane on
day 2 after baculovirus infection, followed by a progres-
sive decrease (Figure 4A). The amount of CHRM2
expressed in P. pastoris gradually increased up to day 3
(Figure 4B). A total of 4 mg of CHRM2 was expressed
from 5 L-culture medium on day 3. In Sf9 insect cells,
2.3 ± 1.1 mg of CHRM2 was the maximum amount
expressed from 5 L-culture medium on day 2, which
then decreased to approximately 1 mg/5 L-culture.
Based on their maximum expression levels, CHRM2 was
e x p r e s s e da ta na l m o s t2 - f o l dh i g h e rl e v e li nP. pastoris
than in Sf9 insect cells per 5 L-culture medium (Figure
4B). High cell density in P. pastoris enabled the produc-
tion of higher quantities of CHRM2 compared to the
amounts produced in Sf9 insect cells.
To compare the quality of the CHRM2 expressed in
P. pastoris to that produced in Sf9 insect cells, the Kd
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Figure 4 Functional comparison of P. pastoris and Sf9 insect cell expression systems. The specific activities of CHRM2 from P. pastoris and
Sf9 insect cells are shown (A). CHRM2 expression was induced by the addition of methanol in P. pastoris and by the infection of baculovirus in
Sf9 insect cells. The total CHRM2 protein (mg) expressed from 5 L-cultures of P. pastoris and Sf9 insect cells was assessed by a specific ligand
binding assay (B). To compare the quality of CHRM2 from P. pastoris (C) and Sf9 insect cells (D), biochemical properties were evaluated by Kd
and Bmax values from saturation curves and scattered plots.
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Page 6 of 13values for the binding of [
3H]QNB to CHRM2 in both
expression systems were calculated from Scatchard plots
of the saturation binding experiments (Figure 4C and
4D). A representative figure of the saturation binding
assay and the Scatchard plot from P. pastoris are shown
in Figure 4C. The Bmax value was 33.5 ± 7.08 pmol/mg
of membrane protein and the Kd value was 101.14 ±
15.07 pM. A representative figure of the saturation bind-
ing assay and the Scatchard plot from Sf9 insect cells
are shown in Figure 4D. The Bmax value was 27.17 ±
5.57 pmol/mg-membrane and the Kd value was 86.23 ±
8.57 pM. These results indicated that the CHRM2
obtained from both expression systems had a nearly
identical quality.
Solubilization and purification of CHRM2 expressed in P.
Pastoris
In a GPCR structural study, it is important to determine
whether the GPCRs are able to be solubilized and
purified. Therefore, we attempted the solubilization and
purification of CHRM2 from P. pastoris (Figure 5). The
purity of CHRM2 from P. pastoris progressively
increased with each purification step. The specific activ-
ity of CHRM2 after ConA flow-through reached >2000
pmol/mg of protein, and was approximately 100 times
higher than that of CHRM2 in the membrane (Figure
5A). CHRM2 purified by TALON metal affinity resin
appeared as dimerized CHRM2, and impurities were
identified in the SDS-PAGE and Coomassie Brilliant
Blue (CBB) stain (Figure 5B). However, after ConA agar-
ose purification, CHRM2 was well purified and observed
as a single monomer band. These results showed that
CHRM2 from P. pastoris could be solubilized and
purified to the same extent as protein from Sf9 insect
cells [52]. Impurities were removed at every purification
step; however, purification with ConA agarose particu-
larly removed a large amount of impurities (Figure 5B).
Comparison of other GPCRs expressed in P. Pastoris and
Sf9 insect cells
To show that many GPCRs can be isolated successfully
from P. pastoris for crystal structural analysis, we inves-
tigated the specific binding activities of 5 mammalian
GPCRs expressed in P. pastoris and Sf9 insect cells
(Table 1). Human ADORA2A, tachykinin receptor 2
(TACR2), dopamine receptor D2 (DRD2), angiotensin
receptor type 2 (AGTR2), and rat TACR2 were
expressed in P. pastoris and Sf9 insect cells similar to
CHRM2. Each GPCR was subjected to a binding assay
using radioisotope-labeled specific ligands.
For ADORA2A, the specific activity was extremely
high (>200 pmol/mg of membrane) compared with the
other GPCRs. However, there was no difference in activ-
ity between ADORA2A expressed in P. pastoris or Sf9
insect cells. For human and rat TACR2, the specific
activities for GPCRs expressed in P. pastoris were 2.5-
6.5 times higher than those expressed in Sf9 insect cells.
T h es p e c i f i ca c t i v i t i e so fh u m a nD R D 2a n dA G T R 2
from P. pastoris were 1.3-2.2 times higher than those
expressed in Sf9 insect cells. These results suggest that
P. pastoris is a suitable host for GPCR structural studies
comparable to Sf9 insect cells.
Discussion
Insect cells such as Sf9 and High5 are the preferred
expression hosts for the determination of the crystal
structure of GPCRs [40-42,55]. However, the use of
P. pastoris as a host system for the expression of GPCRs
offers several advantages. P. pastoris is capable of
expressing heterologous genes at high levels under the
control of the strong and tightly regulated AOX1 pro-
moter, and has already been used as an effective host
for the X-ray crystallographic studies of the Kv channel
[53,56,57]. This methylotrophic yeast combines several
advantages of both prokaryotic and animal cell expres-
sion systems. It is readily amenable to genetic manipula-
tion, it can be easily grown to high cell densities using
minimal media, and it possesses the necessary elements
to introduce eukaryotic posttranslational modifications.
The present study compared Sf9 insect cells and P. pas-
toris as expression systems for the production of GPCRs
for crystallization and structural analysis. As shown in
Figure 2, culture conditions including cell density,
nutrient metabolism and pH were monitored during the
production of CHRM2 as a model protein in Sf9 insect
cells and P. pastoris.
The cell density of P. pastoris increased up to day 3
during methanol induction, and then began to decrease
as the culture was starved of dissolved oxygen (dO2)
and nutrients (Figure 2A). As a result, the concentration
of P. pastoris-expressed CHRM2 was highest on day
3 after methanol induction (Figure 4B). On the other
hand, the highest expression level in Sf9 insect cells,
which was obtained on day 2 (2.0 mg/5L-culture),
amounted to one half of the maximum expression in
P. pastoris (4.0 mg/5L-culture) (Figure 4B). The viability
of insect cells decreased by 50% in two days after bacu-
lovirus infection (Figure 2D), whereas the cell density in
P. pastoris increased until the maximum expression
level was reached on day 3 (Figure 2A). Western blot-
ting to detect CHRM2 revealed significant proteolytic
degradation of the expressed protein in Sf9 insect cells
[58]. Proteolytic degradation in virus-infected insect
cells can be attributed to the action of carboxyl and
cysteine proteases [59]. Addition of aprotinin and pep-
statin A, which are inhibitors of carboxyl and cysteine
proteases, respectively, to a virus-infected insect cell cul-
ture increased the yield of the infectious bursal disease
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Page 8 of 13virus structural protein nearly 2-fold [60]. The viability
in a virus-infected cell culture might be associated with
the yield of functional CHRM2 obtained in Sf9 insect
cells. An expression level greater than 1 mg/L-culture is
the preferred level for purification and crystallization
experiments. Warne et al. expressed more than 1 mg of
unpurified mutant turkey ADRB1 per liter of culture
using the baculovirus system [13] and improved the
expression level (numbers of functional receptors/mg of
membrane) to 360 pmol/mg solubilized membrane pro-
tein, in addition to enhancing the total expression level.
These results suggest that not only substantial quantities
but also expression levels are critical factors for struc-
tural analysis.
To determine whether the recombinant CHRM2
expressed in P. pastoris and Sf9 insect cells was different
in quality, a Scatchard analysis was performed from a
saturation [
3H]QNB binding experiment to determine a
dissociation constant (Kd). The Kd values measured in
the present study from P. pastoris (101.14 ± 15.07 pM)
and Sf9 insect cells (86.23 ± 8.57 pM) were comparable
to those reported by previous studies. A Kd value of 25.7
pM and a Bmax value of 5.55 pmol/mg protein were
reported for Sf9 insect cells [17]. A Kd value of 113.7 pM
and a Bmax value of 51.2 pmol/mg were reported for P.
pastoris [29], suggesting the absence of significant differ-
ences in ligand binding activity between the two systems.
The expression of cell surface molecules was monitored
by flow cytometry to assess the production of properly
folded proteins in the baculovirus expression system [61].
Cell surface expression of CHRM2 may result in differ-
ences between receptors produced in P. pastoris and Sf9
insect cells. However, surface expression, G-protein cou-
pling and second messenger generation other than
saturation ligand binding should be investigated to evalu-
ate the sample grade for structural analysis.
As shown in Figure 3, the conditions used for the
expression of CHRM2 in P. pastoris using a flask
method were optimized based on a previously published
method [29]. Flask cultures enable the application of
several expression conditions in parallel and require
limited equipment compared to bioreactor-based sys-
tems [27]. The addition of methanol to the P. pastoris
culture every 24 hr allows the control of the amount of
nutrients added to the culture (Figure 2B). In the insect
culture system, 35% of the glucose added as a nutrient
to the cell culture medium had already been consumed
at the time of baculovirus infection (Figure 2E).
However, methanol concentration must be kept within a
narrow range because excess formaldehyde produced by
the oxidation of methanol by AOX1 can accumulate to
cytotoxic levels [62]. The optimum pH range for stabili-
zation and activity differs for each GPCR and should
therefore be adjusted for each receptor during induction.
The P. pastoris expression system enables the adjust-
ment of pH, as shown in Figure 3, which shows that
t h e r ew e r en ov a r i a t i o n si np Hv a l u e sd u r i n gt h ef i r s t
three days after induction (Figure 2C).
It is important that GPCRs expressed from P. pastoris
are evaluated for their solubilization and purification
efficacy compared to proteins expressed from insect
cells. The specific binding activities of CHRM2 and 5
other GPCRs expressed from P. pastoris and Sf9 insect
cells were investigated (Figure 4 and Table 1). The spe-
cific activities of these GPCRs from P. pastoris were
higher than those from Sf9 insect cells. Functional
CHRM2 expressed from P. pastoris was solubilized and
purified similar to CHRM2 expressed from Sf9 insect
cells [52] (Figure 5).
Although previous studies have used P. pastoris as a
GPCR expression host [24-29], to our knowledge this
study is the first report to compare GPCRs expressed
from P. pastoris directly with those expressed from Sf9
insect cells. The results of this study strongly suggest
that many GPCRs, including CHRM2, can be expressed
from P. pastoris with quality and quantity equal to those
expressed from Sf9 insect cells. We think that GPCRs
expressed from P. pastoris will be usable for crystal
structural analysis.
Conclusion
The present study identified several advantages of
P. pastoris over insect cells as an expression system for
the production of GPCRs for structural studies. Com-
pared to insect cells, the yield of CHRM2 expressed in
P. pastoris was higher and the receptors produced by
P. pastoris were also functional. The optimization of
culture conditions, including pH, induction time and
temperature, was essential to obtain an adequate GPCR
expression level in P. pastoris. Flask culture systems allow
the optimization of several conditions in parallel, and the
optimized conditions can be applied to bioreactor cultures,
Table 1 Comparison of the specific binding activity in
other GPCRs expressed from P. pastoris and Sf9 insect
cells system
GPCR P. pastoris Sf9 Ligand
hADORA2A 220.81 ± 17.05 239.23 ± 47.12 ZM241385
a)
hTACR2 61.96 ± 9.83 9.41 ± 2.46 SR48968
a)
hDRD2 7.75 ± 1.54 5.98 ± 1.17 Spiperone
a)
hAGTR2 3.69 ± 0.42 1.66 ± 0.08 Angiotenin
b)
rTACR2 36.60 ± 12.99 14.2 ± 5.41 SR48968
a)
All GPCRs were expressed under small-scale culture conditions. Each
membrane was prepared from cells, and the specific binding assay was
determined using radioactive-labeled specific ligand respectively. hADORA2A,
human adenosine A2a receptor; hTACR2 and rTACR2, human and rat
tachykinin receptor 2, respectively; hDRD2, human dopamine receptor D2;
hAGTR2, human angiotensin receptor type 2. a, antagonist; b, agonist. The
data are presented as pmol/mg-membrane and mean ± S.D. (n = 3 each).
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Page 9 of 13which yield higher cell densities than flask cultures [27].
The P. pastoris expression system is not only useful for
functional and structural studies but also for the screening
of more stable mutants with high expression levels, such
as N-terminal, C-terminal, and/or third intracellular loop
truncation, replacement of the third intracellular loop by
T4 lysozyme, N-linked glycosylation deletion and other
mutations.
Methods
Materials
The pPIC9K vector and P. pastoris strain SMD1163
were purchased from Invitrogen. Sf9 insect cells and
recombinant CHRM2 baculovirus were prepared as
described previously [52]. IPL-41 insect medium was
purchased from AppliChem. ESF-921 insect medium
was purchased from Expression Systems. SF900II insect
medium, tryptose phosphate, TC extract, Pluronic F-68
and fetal bovine serum were purchased from Invitrogen.
Penicillin-streptomycin mixture was purchased from
Wako. [
3H]QNB (quinuclindinyl benzilate, 1.74 TBq/
mmol) were obtained from GE Healthcare. Atropine
was purchased from Sigma. GF/F glass fiber filters were
purchased from Whatman and protease inhibitor cock-
tail tablets (Complete) were purchased from Roche
Diagnostics.
Construction of CHRM2 encoding vector for P. pastoris
CHRM2 cDNA was subcloned into the pPIC9K expres-
sion vector and linearized using the restriction enzyme
PmeI. The linearized vector was transformed into the P.
pastoris strain SMD1163 by electroporation (1500 V, 25
μF, and 600 Ω) using a Gene Pulser I (Bio Rad). Clone
selection was performed as previously described [63,64].
In brief, recombinant His
+ clones were selected on MD
agar plates (1.34% (w/v) yeast nitrogen base without
amino acids, 2% (w/v) dextrose, 0.00004% (w/v) biotin,
and 1.5% (w/v) agar). To select for multicopy transfor-
mants, His
+ clones were grown on G418-YPD
agar plates (1% (w/v) yeast extract, 2% (w/v) peptone,
2% (w/v) dextrose, 2% (w/v) agar, and 0.1 or 0.25 mg/ml
G418). Representative clones exhibiting resistance to
G418 were tested for recombinant protein production
by specific ligand binding assays using [
3H]QNB. The
selected transformants were stored as glycerol stocks at
-80°C.
Small scale culture for P. pastoris
Glycerol stocks of the transformants were inoculated onto
YPD agar plates containing 0.1 mg/ml G418. For receptor
production, cells were precultured in 5 ml BMGY medium
(1% (w/v) yeast extract, 2% (w/v) peptone, 1.34% (w/v)
yeast nitrogen base without amino acids, 0.00004% (w/v)
biotin, 1% (w/v) glycerol, and 0.1 M phosphate buffer at
pH 6.0) at 30°C with shaking at 250 rpm until an OD600 of
2 - 6w a sr e a c h e d .I n d u c t i o no fC H R M 2e x p r e s s i o nw a s
conducted in 5 ml BMMY medium (1% (w/v) yeast
extract, 2% (w/v) peptone, 1.34% (w/v) yeast nitrogen base
without amino acids, 0.00004% (w/v) biotin, 1% (v/v)
methanol, and 0.1 M phosphate buffer at pH 6.0, 7.0, or
8.0) containing 0.04% (w/v) histidine and 3% (v/v) DMSO
at 20 or 30°C from an initial OD600 of 1. The procedure
used for P. pastoris culture was described previously [29].
After a 20, 40, or 60 hour induction, cells were harvested
at 4,000 g for 15 min, washed once with ice cold water,
and frozen or immediately used for membrane
preparation.
Large scale culture for P. pastoris
Single P. pastoris colonies from high expressing clones
were selected on YPD plates containing 0.1 mg/ml
G418. Cells from a single colony were used to inoculate
200 ml of BMGY medium. The culture was grown over-
night at 30°C to an OD600 of 2-6. A total of 500 ml of
BMGY was inoculated with 100 ml of the starter culture
and grown for 4 hr to an OD600 of 5-10. The cells were
spun down at 4,000 g for 15 min, the cell pellet was
washed with double distilled water, and then the cells
were spun down. The cell pellet was resuspended in 500
ml BMMY to an OD600 of 1. The culture was incubated
for 1-4 days at 20°C with shaking at 250 rpm, and then
25 ml of 20% methanol was added to the cell culture to
maintain a final methanol concentration of 1% every day
until the end of the culture period.
Small scale culture for Sf9 insect cells
Sf9 insect cells were maintained in IP-41-based medium
or ESF-921 medium each containing 3.5, 5 or 7% heat-
inactivated fetal bovine serum. Preparation of culture
medium was described previously [65]. Briefly, complete
culture media were mixed at a ratio of 70% IPL-41 med-
ium to 30% SF900II serum free medium and supple-
mented with 0.1% pluronic F-68 and 3.5 or 7% FBS. The
small scale culture was carried out to transfer to large
scale culture using a wave bioreactor (GE Healthcare).
Sf9 insect cells were cultured in Erlenmeyer flasks with
the 125 rpm at 27°C culture conditions and passaged
every 3 or 4 days.
Large scale culture for Sf9 insect cells
Sf9 insect cells were prepared at a density of 1.0 × 10
6
cells/ml and suspended in 5 L of the IPL-41/SF900 II
complex media or ESF921 insect media. Media contain-
ing Sf9 insect cells were transferred into the CELLBAG
22 L/O (GE Healthcare) [66,67] and cultured for 4 days
with the following culture conditions: 20 rpm, 8.5° of
rocking angle, 30% O2, 0.25 L/min of air flow rate, and
27°C. After 4 days, 200~300 ml of baculovirus stock
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700~800 ml of IPL-41/SF900 II complex media were
transferred into the CELLBAG (final culture volume = 6
L) and infected for 2 days under the following infection
conditions: 22 rpm, 8.5° of rocking angle, 50% O2,a i r
flow rate, 0.25 L/min, and 27°C. Two days later, a frac-
tion of the cells was harvested for the binding assay and
the remaining cells were centrifuged at 6,000 × g for 10
min and harvested. The cell pellet was washed with
250 ml of Phosphate Buffered Saline without calcium
chloride and magnesium chloride (PBS(-)) and resus-
pended with 100 ml of PBS(-) containing a protease
inhibitor cocktail tablet (Roche). Cells were quick frozen
in liquid nitrogen and stored at -80°C.
Preparation of the cell membrane
The preparation of cell membranes from P. pastoris was
performed at 4°C or on ice. Harvested cells (1 g of wet
weight) were suspended in 4 ml of lysis buffer (50 mM
sodium phosphate buffer, pH 7.4, 100 mM NaCl, 5%
(v/v) glycerol, and 2 mM EDTA) containing a cocktail
of protease inhibitors (1 tablet/100 ml lysis buffer).
After the addition of 0.5 mm glass beads to the cell sus-
pension, yeast cells were disrupted by vortexing at 4°C
for 2 hr. Lysis efficiency was evaluated using a light
microscope and was usually more than 80%. Intact cells
and cell debris were separated from the membrane sus-
pension by low speed centrifugation (3,000 g, 5 min and
4°C). Membranes were snap-frozen in liquid nitrogen
and stored at -80°C.
For the preparation of membranes from insect cells,
Sf9 insect cells were centrifuged at 1,500 g for 10 min at
4°C. The pellet was washed with PBS(-), then resus-
pended in 100 ml of hypotonic buffer containing
10 mM HEPES at pH 7.5, 20 mM potassium chloride,
10 mM MgCl2, and protease inhibitor cocktail, followed
by Dounce homogenization to resuspend the mem-
branes. Insect cell membranes were centrifuged at
100,000 g for 30 min and the pellets were resuspended
in 10 mM HEPES at pH 7.5, 10 mM magnesium chlor-
ide, 20 mM potassium chloride, and 40% glycerol, and
then flash-frozen in liquid nitrogen and stored at -80°C
until further use.
Solubilization and purification of CHRM2
Membrane suspensions of the CHRM2 were solubilized
in solubilization buffer containing 20 mM HEPES, pH
7.0, 500 mM NaCl, 20% glycerol, 1% n-dodecyl-b-D-mal-
topyranoside (DDΜ) (Affymetrix), 0.2% cholesterol hemi-
succinate (CHS) (Sigma), and protease inhibitor cocktail
at 4°C for 2 hr. The insoluble materials were pelleted by
ultracentrifugation at 200,000 g for 1 hr at 4°C. TALON
metal affinity resin (Clontech) equilibrated in purification
buffer (20 mM HEPES, pH 7.0, 800 mM NaCl, 10%
glycerol, 0.05% DDM, 0.01% CHS and protease inhibitor
cocktail) was added to the solubilized membranes and
incubated for 2 hr at 4°C. CHRM2 protein was eluted
with purification buffer containing 250 mM imidazole.
ConA agarose (Seikagaku Corporation) equilibrated in
purification buffer was added to the TALON-purified
CHRM2 and incubated overnight at 4°C. The ConA agar-
ose flow-through fraction was harvested. The purified
CHRM2 protein was subjected to SDS-PAGE, CBB
staining, and a specific binding assay.
Radioligand binding assay
Binding assays were conducted in polystyrol tubes using
assay buffer (20 mM potassium phosphate buffer). GF/F
glass filters were presoaked in 200 ml of 0.3% (v/v) poly-
ethyleneimine. All experiments were performed in dupli-
cate in a total volume of 200 μl. Membrane proteins
were quantified using the bicinchoninic acid (BCA)
method (Thermo Fisher Scientific) with bovine serum
albumin as a standard. Membrane proteins (2.5 μg)
were incubated for 30 min at 25°C in 200 μlo fa s s a y
buffer containing 1.5 nM [
3H]QNB for single point
binding assays at saturating radioligand concentrations.
Non-specific binding was obtained by incubation in the
presence of an excess of the non-radioactive ligand,
namely in 100 μM atropine. Bound and free ligands
were separated by rapid vacuum filtration over GF/F fil-
ters. Filtration was carried out with a Brandel cell har-
vester at room temperature. Filters were washed three
times with ice cold water. The retained radioactivity was
measured on an LCS-5100 liquid scintillation counter
(ALOKA).
Experimental design and Statistical evaluation
Experiments in each group were repeated independently
at least 3 times. The Kd and Bmax values were esti-
mated using the saturation binding assay and Scatchard
plots. Data are presented as the means ± standard devia-
tion (S.D.).
Additional material
Additional File 1: Fig. S1. Morphological change of Sf9 insect cell
by baculovirus infection. Healthy, uninfected Sf9 insect cells (A) and
cells 2 days after baculovirus infection (B) were mounted on slide glass
and observed under bright-field microscopy. (×40) (Scale bar, 10 μm.
Images were independently observed 3 times and representative images
are shown.
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